CGMs have saved my life after a heart attack four years ago. I recently tried the Dexcom Stelo OTC CGM, and it's been mighty ...

DexCom faces challenges in 2024 due to competition and missteps, but the long-term outlook for continuous glucose monitors ...

SAN DIEGO, September 26, 2024--DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its third ... maladie du Québec (RAMQ) Public Prescription Drug Insurance Plan.

Dexcom has said it intends to launch Stelo in the summer, but has not yet revealed its pricing plans for the product. Typically, a patient paying out of pocket for a prescription CGM would be on ...

Dexcom and ŌURA announce a strategic partnership to help millions of people improve their metabolic health through the integration of Dexcom glucose data with vital sign, sleep, stress, heart ...

Dexcom continues to offer its leading CGM systems, along with Stelo, its recently launched over-the-counter glucose biosensor. Combining its OTC CGM offering with the retail-available Oura Ring ...

Dexcom makes continuous glucose monitoring devices, including a prescription-free device named Stelo. The two companies plan to integrate glucose monitoring data from Dexcom's machines and app ...

DexCom, Inc. (DXCM), headquartered in California, is a leading player in the medical devices sector. Valued at a market cap of $30.4 billion, the company specializes in continuous glucose ...

Oura is partnering with medical device maker Dexcom to integrate data from glucose ... according to Oura CEO Tom Hale. Oura plans to use the $75 million in fresh funding to expand its footprint ...

DexCom has generally sought to enter new territories in the past, though. The company explicitly plans to continue doing so. Second, CGM systems can get more third-party coverage as the evidence ...